PMID: 15218958Jun 29, 2004Paper

Bone marrow cells and myocardial regeneration

International Journal of Hematology
Fu-Sheng Wang, Cathy Trester

Abstract

Hematopoietic stem cell (HSC) plasticity and its clinical application have been studied profoundly in the past few years. Recent investigations indicate that HSC and other bone marrow stem cells can develop into other tissues. Because of the high morbidity and mortality of myocardial infarction and other heart disorders, myocardial regeneration is a good example of the clinical application of HSC plasticity in regenerative medicine. Preclinical studies in animals suggest that the use of this kind of treatment can reconstruct heart blood vessels, muscle, and function. Some clinical study results have been reported in the past 2 years. In 2003, reports of myocardial regeneration treatment increased significantly. Other studies include observations on the cell surface markers of transplanted cells and treatment efficacy. Some investigations, such as HSC testing, have focused on clinical applications using HSC plasticity and bone marrow transplantation to treat different types of disorders. In this review, we focus on the clinical application of bone marrow cells for myocardial regeneration.

References

Mar 13, 1999·The Journal of Clinical Investigation·S MakinoS Ogawa
Apr 1, 1999·Annual Review of Physiology·P D Kessler, B J Byrne
Mar 18, 2000·Science·G Vogel
Oct 20, 2000·Heart·A A Hagège, P Menasché
Feb 15, 2001·Journal of Hematotherapy & Stem Cell Research·R Mertelsmann
Apr 3, 2001·Nature Medicine·N Rosenthal, L Tsao
Apr 5, 2001·Nature·D OrlicP Anversa
Jun 1, 2001·The Annals of Thoracic Surgery·R M El OakleyM H Yacoub
Jun 8, 2001·The Journal of Clinical Investigation·K A JacksonM A Goodell
Jun 8, 2001·The American Journal of Pathology·N N MaloufP A Anderson
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·G CondorelliG Cossu
Dec 18, 2001·Journal of Applied Physiology·Jiang-Yong MinYong-Fu Xiao
Jan 5, 2002·The New England Journal of Medicine·Federico QuainiPiero Anversa
Jan 11, 2002·Blood Cells, Molecules & Diseases·P QuesenberryP Becker
May 4, 2002·Seminars in Thoracic and Cardiovascular Surgery·Philippe Menasché
May 9, 2002·The Annals of Thoracic Surgery·Kimikazu HamanoMasunori Matsuzaki
May 29, 2002·Gene Therapy·D S Krause
May 29, 2002·Gene Therapy·K K Hirschi, M A Goodell
Jun 4, 2002·Current Opinion in Hematology·John F Tisdale, Cynthia E Dunbar
Jun 6, 2002·Journal of Cellular Biochemistry. Supplement·James T Triffitt
Jun 6, 2002·Journal of Cellular Biochemistry. Supplement·William T Tse, Matthew C Egalka
Jun 12, 2002·Immunology Letters·Robert Keller
Jun 22, 2002·Nature·Yuehua JiangCatherine M Verfaillie
Jul 13, 2002·The Journal of Pathology·Richard PoulsomNicholas A Wright
Jul 13, 2002·The Journal of Pathology·Siân Hughes
Jul 26, 2002·Progress in Cardiovascular Diseases·Marc S PennEric J Topol
Jul 31, 2002·Congestive Heart Failure·Jochen Müller-EhmsenRobert A Kloner
Aug 8, 2002·Neuron·Jonas Frisén
Aug 10, 2002·Circulation Research·Kenneth R BohelerAnna M Wobus
Aug 13, 2002·Current Pharmaceutical Design·G PelledD Gazit
Sep 3, 2002·Journal of Neuroscience Research·Juan R Sanchez-Ramos
Sep 5, 2002·Medical Hypotheses·Gitte S Jensen, Christian Drapeau
Sep 21, 2002·Lancet·Eriko Tateishi-YuyamaUNKNOWN Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators
Oct 4, 2002·Comptes rendus biologies·Philippe Menasché
Nov 15, 2002·International Journal of Hematology·Donald Orlic
Nov 20, 2002·Journal of the American College of Surgeons·Christopher D RaeburnAlden H Harken
Nov 20, 2002·Herz·Thomas J Dengler, Hugo A Katus
Dec 24, 2002·Comptes rendus biologies·Neil D Theise
Jan 9, 2003·Lancet·Roger J Laham, Peter Oettgen
Jan 9, 2003·Lancet·Christof StammGustav Steinhoff
Jan 23, 2003·The Journal of Cardiovascular Nursing·Sean L SavitzDaniel M Rosenbaum

❮ Previous
Next ❯

Citations

Jun 23, 2007·The Journal of Surgical Research·George M WairiukoDaniel R Meldrum
Mar 27, 2009·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Xiaobing FuZhiyong Sheng
Oct 29, 2005·Nuclear Medicine and Biology·Shinji TakamatsuYasuhisa Fujibayashi
Feb 24, 2009·Biochemical and Biophysical Research Communications·Emel KaplanJames P Morgan
Dec 17, 2004·Journal of Cellular and Molecular Medicine·S FilipJ Mokrý

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Annals of the New York Academy of Sciences
Giulio AlessandriPaolo Madeddu
Archives of Medical Research
José-Manuel BaizabalLuis Covarrubias
The International Journal of Biochemistry & Cell Biology
Frank P Barry, J Mary Murphy
Transplant Immunology
H David Humes, Mark S Szczypka
© 2022 Meta ULC. All rights reserved